Cargando…

Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis

BACKGROUND: Mass COVID-19 vaccination campaigns have helped impede the COVID-19 pandemic. In rare cases, some vaccines have led to vaccine associated myocarditis in a specific subset of the population, usually young males. Cardiac magnetic resonance (CMR) can reliably diagnose vaccine associated myo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kravchenko, Dmitrij, Isaak, Alexander, Mesropyan, Narine, Bischoff, Leon M., Pieper, Claus C., Attenberger, Ulrike, Kuetting, Daniel, Zimmer, Sebastian, Hart, Christopher, Luetkens, Julian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682292/
https://www.ncbi.nlm.nih.gov/pubmed/36440045
http://dx.doi.org/10.3389/fcvm.2022.1049256
_version_ 1784834819744595968
author Kravchenko, Dmitrij
Isaak, Alexander
Mesropyan, Narine
Bischoff, Leon M.
Pieper, Claus C.
Attenberger, Ulrike
Kuetting, Daniel
Zimmer, Sebastian
Hart, Christopher
Luetkens, Julian A.
author_facet Kravchenko, Dmitrij
Isaak, Alexander
Mesropyan, Narine
Bischoff, Leon M.
Pieper, Claus C.
Attenberger, Ulrike
Kuetting, Daniel
Zimmer, Sebastian
Hart, Christopher
Luetkens, Julian A.
author_sort Kravchenko, Dmitrij
collection PubMed
description BACKGROUND: Mass COVID-19 vaccination campaigns have helped impede the COVID-19 pandemic. In rare cases, some vaccines have led to vaccine associated myocarditis in a specific subset of the population, usually young males. Cardiac magnetic resonance (CMR) can reliably diagnose vaccine associated myocarditis, but follow-up data of CMR proven acute myocarditis is scarce. MATERIALS AND METHODS: Nine patients with acute vaccine associated myocarditis underwent baseline and follow-up CMR examinations and were compared to baseline parameters at initial presentation and to a group of 20 healthy controls. CMR protocol included functional assessment, T1 and T2 mapping, T2 signal intensity ratio, strain feature tracking, and late gadolinium enhancement (LGE). RESULTS: Myocarditis patients (n = 9, aged 24 ± 6 years, 8 males) underwent CMR follow-up after an average of 5.8 ± 4.3 months. All patients showed a complete resolution of visual myocardial edema while also demonstrating a reduction in overall LGE extent from baseline to follow-up (4.2 ± 2.1 vs. 0.9 ± 0.8%, p < 0.001), although visual LGE was still noted in all patients. Left ventricular ejection fraction was normal at baseline and at follow-up (58 ± 6 vs. 62 ± 4%, p = 0.10) as well as compared to a healthy control group (60 ± 4%, p = 0.24). T1 (1024 ± 77 vs. 971 ± 34 ms, p = 0.05) and T2 relaxations times (57 ± 6 vs. 51 ± 3 ms, p = 0.03) normalized at follow-up. Most patients reported a resolution of clinical symptoms, while two (22%) reported new onset of exertional dyspnea. CONCLUSION: Patients with COVID-19 vaccine associated acute myocarditis showed a complete, uncomplicated resolution of myocardial inflammation on follow-up CMR, which was associated with a near complete resolution of symptoms. Minor, residual myocardial scarring was present on follow-up LGE imaging. The long-term implications of the remaining myocardial scar-tissue after vaccine associated myocarditis remain unknown warranting further studies.
format Online
Article
Text
id pubmed-9682292
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96822922022-11-24 Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis Kravchenko, Dmitrij Isaak, Alexander Mesropyan, Narine Bischoff, Leon M. Pieper, Claus C. Attenberger, Ulrike Kuetting, Daniel Zimmer, Sebastian Hart, Christopher Luetkens, Julian A. Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Mass COVID-19 vaccination campaigns have helped impede the COVID-19 pandemic. In rare cases, some vaccines have led to vaccine associated myocarditis in a specific subset of the population, usually young males. Cardiac magnetic resonance (CMR) can reliably diagnose vaccine associated myocarditis, but follow-up data of CMR proven acute myocarditis is scarce. MATERIALS AND METHODS: Nine patients with acute vaccine associated myocarditis underwent baseline and follow-up CMR examinations and were compared to baseline parameters at initial presentation and to a group of 20 healthy controls. CMR protocol included functional assessment, T1 and T2 mapping, T2 signal intensity ratio, strain feature tracking, and late gadolinium enhancement (LGE). RESULTS: Myocarditis patients (n = 9, aged 24 ± 6 years, 8 males) underwent CMR follow-up after an average of 5.8 ± 4.3 months. All patients showed a complete resolution of visual myocardial edema while also demonstrating a reduction in overall LGE extent from baseline to follow-up (4.2 ± 2.1 vs. 0.9 ± 0.8%, p < 0.001), although visual LGE was still noted in all patients. Left ventricular ejection fraction was normal at baseline and at follow-up (58 ± 6 vs. 62 ± 4%, p = 0.10) as well as compared to a healthy control group (60 ± 4%, p = 0.24). T1 (1024 ± 77 vs. 971 ± 34 ms, p = 0.05) and T2 relaxations times (57 ± 6 vs. 51 ± 3 ms, p = 0.03) normalized at follow-up. Most patients reported a resolution of clinical symptoms, while two (22%) reported new onset of exertional dyspnea. CONCLUSION: Patients with COVID-19 vaccine associated acute myocarditis showed a complete, uncomplicated resolution of myocardial inflammation on follow-up CMR, which was associated with a near complete resolution of symptoms. Minor, residual myocardial scarring was present on follow-up LGE imaging. The long-term implications of the remaining myocardial scar-tissue after vaccine associated myocarditis remain unknown warranting further studies. Frontiers Media S.A. 2022-11-09 /pmc/articles/PMC9682292/ /pubmed/36440045 http://dx.doi.org/10.3389/fcvm.2022.1049256 Text en Copyright © 2022 Kravchenko, Isaak, Mesropyan, Bischoff, Pieper, Attenberger, Kuetting, Zimmer, Hart and Luetkens. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Kravchenko, Dmitrij
Isaak, Alexander
Mesropyan, Narine
Bischoff, Leon M.
Pieper, Claus C.
Attenberger, Ulrike
Kuetting, Daniel
Zimmer, Sebastian
Hart, Christopher
Luetkens, Julian A.
Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis
title Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis
title_full Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis
title_fullStr Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis
title_full_unstemmed Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis
title_short Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis
title_sort cardiac magnetic resonance follow-up of covid-19 vaccine associated acute myocarditis
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682292/
https://www.ncbi.nlm.nih.gov/pubmed/36440045
http://dx.doi.org/10.3389/fcvm.2022.1049256
work_keys_str_mv AT kravchenkodmitrij cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis
AT isaakalexander cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis
AT mesropyannarine cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis
AT bischoffleonm cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis
AT pieperclausc cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis
AT attenbergerulrike cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis
AT kuettingdaniel cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis
AT zimmersebastian cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis
AT hartchristopher cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis
AT luetkensjuliana cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis